|

Parkinson's Disease Clinical Trials in Illinois

20 recruiting studies across 1 city

Browse by City

Chicago
20 trials

All Trials in Illinois

Phase
Trial Phase Dist.
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 22 mi
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's DiseaseN/A2 mi
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 32 mi
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)—2 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease—2 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 22 mi
Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)Phase 1/22 mi
Parkinson's Foundation PD GENEration Genetic Registry—2 mi
rTMS to Improve Cognition in Parkinson'sPhase 1/22 mi
Sensory-specific Peripheral Stimulation for Tremor ManagementN/A2 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—2 mi
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease—2 mi
Use of CereGate Therapy for Freezing of Gait in PDN/A2 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/32 mi
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—2 mi
Remote Therapeutic Monitoring Exercise TrackingN/A2 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 411 mi
A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson'sPhase 312 mi
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseasePhase 220 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 427 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.